[Patient survival following radiofrequency ablation of liver metastases from colorectal cancer].
The objective of the work was to evaluate five-year survival rates of patients with liver metastases from colorectal cancer following radiofrequency ablation (RFA). MATERIAL A METHOD: The authors prospectively evaluated a set of 32 patients indicated for radiofrequency ablation. Patients who were indicated for RFA and for a combination of liver resection with RFA for metastasis from colorectal cancer had a one-year, three-year and five-year survival of 81%, 31% and 13%, respectively. Therefore 10 patients survived 3 years following the procedure and of these 4 obtained five-year survival. Radiofrequency ablation has become a generally accepted technique in the treatment of liver metastases. It is indicated in cases of lesions unsuitable for surgical resection, either due to large number and location or in patients with comorbidities where an extensive resection is contraindicated. Radiofrequency ablation has minimal complications and is considered on the borderline between a palliative and radical procedure.